NEVVI Medicare utilization intelligence

← back

FAHED, ELIEM.D. NPI 1356492482 Clinician

Medical Oncology · CASPER, WY

Specialty Medical Oncology — from billed Medicare claims
In practice about 21 years since medical school (class of 2005, self-reported to CMS)
Location CASPER, WY · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 61 codes billed · 94,493 disclosed volume (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
ROCKY MOUNTAIN ONCOLOGY CENTER LLC
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2016-03

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Volume Beneficiary-episodes Avg charge Avg Medicare payment
J0185 Injection, aprepitant, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J0897 Injection, denosumab, 1 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
Q5129 Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1437 Injection, ferric derisomaltose, 10 mg
J2469 Injection, palonosetron hcl, 25 mcg
Q5127 Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg
J0640 Injection, leucovorin calcium, per 50 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
36415 Insertion of needle into vein for collection of blood sample
J9190 Injection, fluorouracil, 500 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
J9045 Injection, carboplatin, 50 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96413 Administration of chemotherapy into vein, 1 hour or less
96372 Injection of drug or substance under skin or into muscle
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
J3480 Injection, potassium chloride, per 2 meq
Q5108 Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg
96375 Injection of additional new drug or substance into vein
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
96417 Administration of additional new drug or substance into vein, 1 hour or less
J1200 Injection, diphenhydramine hcl, up to 50 mg
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96415 Administration of chemotherapy into vein, each additional hour
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
J3490 Unclassified drugs
82378 Carcinoembryonic antigen (cea) protein level
J3475 Injection, magnesium sulfate, per 500 mg
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
83615 Lactate dehydrogenase (enzyme) level
82728 Ferritin (blood protein) level
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
J3489 Injection, zoledronic acid, 1 mg
71260 Ct scan of chest with contrast
84443 Blood test, thyroid stimulating hormone (tsh)
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
86304 Immunologic analysis for detection of tumor antigen, quantitative; ca 125
74177 Ct scan of abdomen and pelvis with contrast
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
84153 Psa (prostate specific antigen) measurement, total
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
A9592 Copper cu-64, dotatate, diagnostic, 1 millicurie
83540 Iron level
80048 Blood test, basic group of blood chemicals (calcium, total)
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
83735 Magnesium level
83550 Iron binding capacity
78816 Nuclear medicine study whole body with ct scan
96523 Irrigation of implanted venous access drug delivery device
J2997 Injection, alteplase recombinant, 1 mg
G6015 Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session
J7030 Infusion, normal saline solution , 1000 cc
70491 Ct scan of soft tissue of neck with contrast
71250 Ct scan of chest without contrast

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.